{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:08:43Z","timestamp":1754161723878,"version":"3.41.2"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:00:00Z","timestamp":1749945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07553","19K08011"],"award-info":[{"award-number":["22K07553","19K08011"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["22K10141"],"award-info":[{"award-number":["22K10141"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020964","name":"Fusion Oriented REsearch for disruptive Science and Technology","doi-asserted-by":"publisher","award":["24K02379","23H04979","JPMJFR231U"],"award-info":[{"award-number":["24K02379","23H04979","JPMJFR231U"]}],"id":[{"id":"10.13039\/501100020964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003382","name":"Core Research for Evolutional Science and Technology","doi-asserted-by":"publisher","award":["JPMJCR22P3"],"award-info":[{"award-number":["JPMJCR22P3"]}],"id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24wm0625312","JP22wm0525036"],"award-info":[{"award-number":["JP24wm0625312","JP22wm0525036"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, & Immunity - Health"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bbih.2025.101036","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T12:04:12Z","timestamp":1750075452000},"page":"101036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prevalence of the anti-CASPR2 autoantibody in patients with somatic symptom disorder accompanied by medically unexplained pain"],"prefix":"10.1016","volume":"47","author":[{"given":"Shingo","family":"Katayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayatri","family":"Nayanar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Suga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Takao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yojiro","family":"Umezaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Toyofuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7503-8044","authenticated-orcid":false,"given":"Hiroki","family":"Shiwaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbih.2025.101036_bib1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/ije\/dyi265","article-title":"The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?","volume":"35","author":"Aggarwal","year":"2006","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.bbih.2025.101036_bib2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/jnnp-2017-315720","article-title":"LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes","volume":"89","author":"Binks","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbih.2025.101036_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103424","article-title":"Is fibromyalgia an autoimmune disorder?","volume":"23","author":"Clauw","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbih.2025.101036_bib4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.neuron.2018.01.033","article-title":"Immune or genetic-mediated disruption of CASPR2 causes pain hypersensitivity due to enhanced primary afferent excitability","volume":"97","author":"Dawes","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.bbih.2025.101036_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1192\/bjp.184.6.470","article-title":"Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders","volume":"184","author":"de Waal","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbih.2025.101036_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144201","article-title":"Passive transfer of fibromyalgia symptoms from patients to mice","volume":"131","author":"Goebel","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbih.2025.101036_bib7","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/bmj.39554.592014.BE","article-title":"Assessment and management of medically unexplained symptoms","volume":"336","author":"Hatcher","year":"2008","journal-title":"Bmj"},{"key":"10.1016\/j.bbih.2025.101036_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jpsychores.2015.03.151","article-title":"Construct validity and clinical utility of current research criteria of DSM-5 somatic symptom disorder diagnosis in patients with fibromyalgia syndrome","volume":"78","author":"H\u00e4user","year":"2015","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.bbih.2025.101036_bib9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.PSY.0000075977.90337.E7","article-title":"Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review","volume":"65","author":"Henningsen","year":"2003","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.bbih.2025.101036_bib10","first-page":"49","article-title":"Somatic symptom disorder","volume":"93","author":"Kurlansik","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.bbih.2025.101036_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2215-0366(16)30375-3","article-title":"Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study","volume":"4","author":"Lennox","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbih.2025.101036_bib13","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.0000000000001326","article-title":"Antibodies to GABAA receptor \u03b11 and \u03b32 subunits: clinical and serologic characterization","volume":"84","author":"Pettingill","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.bbih.2025.101036_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0022-3999(96)00292-9","article-title":"Medically unexplained physical symptoms in primary care: a comparison of self-report screening questionnaires and clinical opinion","volume":"42","author":"Peveler","year":"1997","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.bbih.2025.101036_bib15","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0896-6273(00)81049-1","article-title":"Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels","volume":"24","author":"Poliak","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.bbih.2025.101036_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin","volume":"7","author":"Pollak","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbih.2025.101036_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.imlet.2014.01.009","article-title":"Fibromyalgia and cytokines","volume":"161","author":"Rodriguez-Pint\u00f3","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bbih.2025.101036_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.schres.2019.10.007","article-title":"Detection of autoantibodies against GABA(A)R\u03b11 in patients with schizophrenia","volume":"216","author":"Shiwaku","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbih.2025.101036_bib19","article-title":"Autoantibodies against NCAM1 from patients with schizophrenia cause schizophrenia-related behavior and changes in synapses in mice","volume":"3","author":"Shiwaku","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbih.2025.101036_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbi.2023.03.028","article-title":"Analyzing schizophrenia-related phenotypes in mice caused by autoantibodies against NRXN1\u03b1 in schizophrenia","volume":"111","author":"Shiwaku","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbih.2025.101036_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","article-title":"Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis","volume":"70","author":"Steiner","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bbih.2025.101036_bib22","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1083\/jcb.200305078","article-title":"Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers","volume":"162","author":"Traka","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbih.2025.101036_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"}],"container-title":["Brain, Behavior, & Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354625000948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354625000948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T07:14:27Z","timestamp":1753773267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354625000948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":22,"alternative-id":["S2666354625000948"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2025.101036","relation":{},"ISSN":["2666-3546"],"issn-type":[{"type":"print","value":"2666-3546"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of the anti-CASPR2 autoantibody in patients with somatic symptom disorder accompanied by medically unexplained pain","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2025.101036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101036"}}